tiprankstipranks
Advertisement
Advertisement

AU:NEU Stock Latest News

Neuren launches Investor Hub to bolster engagement as neurological pipeline advances
Company AnnouncementsNeuren launches Investor Hub to bolster engagement as neurological pipeline advances
13d ago
Neuren Pharmaceuticals Updates Daily On‑Market Share Buy‑Back Activity
PremiumCompany Announcements
Neuren Pharmaceuticals Updates Daily On‑Market Share Buy‑Back Activity
13d ago
Neuren Rides 20% DAYBUE Sales Growth and Strong STIX Launch in Q1 2026
PremiumCompany Announcements
Neuren Rides 20% DAYBUE Sales Growth and Strong STIX Launch in Q1 2026
18d ago
Neuren Updates Market on Ongoing On-Market Share Buy-Back
PremiumCompany Announcements
Neuren Updates Market on Ongoing On-Market Share Buy-Back
19d ago
Neuren Pharmaceuticals Outlines Procedures for Virtual Shareholder Meeting
PremiumCompany Announcements
Neuren Pharmaceuticals Outlines Procedures for Virtual Shareholder Meeting
1M ago
Neuren Sets Hybrid 2026 AGM, Puts Director Re-election to Shareholder Vote
PremiumCompany AnnouncementsNeuren Sets Hybrid 2026 AGM, Puts Director Re-election to Shareholder Vote
1M ago
Neuren Files Updated ASX Governance Appendix, Confirms Compliance With Key Standards
Premium
Company Announcements
Neuren Files Updated ASX Governance Appendix, Confirms Compliance With Key Standards
1M ago
Neuren details 2025 progress and governance in latest annual report
Premium
Company Announcements
Neuren details 2025 progress and governance in latest annual report
1M ago
Neuren Updates Market on Ongoing On‑Market Share Buy‑Back
PremiumCompany Announcements
Neuren Updates Market on Ongoing On‑Market Share Buy‑Back
1M ago
Neuren Pharmaceuticals Updates Market on Ongoing Share Buy-Back
PremiumCompany Announcements
Neuren Pharmaceuticals Updates Market on Ongoing Share Buy-Back
1M ago
Neuren Updates Market on Progress of On-Market Share Buy-Back
PremiumCompany Announcements
Neuren Updates Market on Progress of On-Market Share Buy-Back
1M ago
Neuren Cancels Shares Following On-Market Buy-Back
PremiumCompany Announcements
Neuren Cancels Shares Following On-Market Buy-Back
1M ago
Neuren Expands Rett Syndrome Reach as DAYBUE STIX Goes Broadly U.S.-Available
PremiumCompany AnnouncementsNeuren Expands Rett Syndrome Reach as DAYBUE STIX Goes Broadly U.S.-Available
2M ago
Neuren Pharmaceuticals Reports Lapse of 50,000 Conditional Options
Premium
Company Announcements
Neuren Pharmaceuticals Reports Lapse of 50,000 Conditional Options
2M ago
Neuren updates market on ongoing on‑market share buy‑back
Premium
Company Announcements
Neuren updates market on ongoing on‑market share buy‑back
2M ago
Neuren Updates Market on Ongoing On-Market Share Buy-Back
PremiumCompany Announcements
Neuren Updates Market on Ongoing On-Market Share Buy-Back
2M ago
Neuren director Joseph Basile lifts stake with on-market share purchase
PremiumCompany Announcements
Neuren director Joseph Basile lifts stake with on-market share purchase
3M ago
Neuren backs Acadia’s EMA appeal after CHMP rejection of Rett drug trofinetide
PremiumCompany Announcements
Neuren backs Acadia’s EMA appeal after CHMP rejection of Rett drug trofinetide
3M ago
Neuren Highlights Neurodevelopmental Focus and Development Risks in Investor Update
PremiumCompany Announcements
Neuren Highlights Neurodevelopmental Focus and Development Risks in Investor Update
3M ago
Neuren Builds Cash and Pipeline as DAYBUE Royalties Climb in 2025
PremiumCompany AnnouncementsNeuren Builds Cash and Pipeline as DAYBUE Royalties Climb in 2025
3M ago
Neuren profit falls on absence of one-offs as core royalties and R&D spend climb
Premium
Company Announcements
Neuren profit falls on absence of one-offs as core royalties and R&D spend climb
3M ago
Neuren Rides DAYBUE Growth as 2025 Royalties Climb and 2026 Outlook Strengthens
Premium
Company Announcements
Neuren Rides DAYBUE Growth as 2025 Royalties Climb and 2026 Outlook Strengthens
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >